Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
J Dermatolog Treat. 2022 Sep;33(6):2827-2837. doi: 10.1080/09546634.2022.2082354. Epub 2022 May 29.
J Dermatolog Treat. 2022.
PMID: 35635185
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic.
Gkalpakiotis S, Cetkovska P, Arenberger P, Dolezal T, Arenbergerova M, Velackova B, Fialova J, Kojanova M; BIOREP study group.
Gkalpakiotis S, et al. Among authors: velackova b.
Dermatol Ther (Heidelb). 2021 Aug;11(4):1345-1355. doi: 10.1007/s13555-021-00556-2. Epub 2021 Jun 5.
Dermatol Ther (Heidelb). 2021.
PMID: 34089479
Free PMC article.
Item in Clipboard
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).
Tichy M, Kojanova M, Velackova B, Dolezal T, Gkalpakiotis S, Cetkovska P; BIOREP study group.
Tichy M, et al. Among authors: velackova b.
Dermatol Ther. 2022 Oct;35(10):e15772. doi: 10.1111/dth.15772. Epub 2022 Sep 5.
Dermatol Ther. 2022.
PMID: 36065488
Item in Clipboard
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.
Kubeš J, Haas A, Vondráček V, Andrlík M, Navrátil M, Sláviková S, Vítek P, Dědečková K, Prausová J, Ondrová B, Vinakurau Š, Grebenyuk A, Doležal T, Velacková B, Rosina J.
Kubeš J, et al. Among authors: velackova b.
Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):1090-1097. doi: 10.1016/j.ijrobp.2021.02.014. Epub 2021 Feb 12.
Int J Radiat Oncol Biol Phys. 2021.
PMID: 33587990
Item in Clipboard
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.
Decker B, Tuzil J, Lukas M, Cerna K, Bortlik M, Velackova B, Pilnackova B, Dolezal T.
Decker B, et al. Among authors: velackova b.
Expert Rev Gastroenterol Hepatol. 2023 Jan;17(1):99-108. doi: 10.1080/17474124.2023.2161047. Epub 2022 Dec 22.
Expert Rev Gastroenterol Hepatol. 2023.
PMID: 36537197
Item in Clipboard
Cite
Cite